Ginwa Enterprise (Group) Inc. (SHA:600080)

China · Delayed Price · Currency is CNY

4.610

-0.030 (-0.65%)

Sep 30, 2026, 3:00 PM CST

Market Cap	1.64B -35.4%
Revenue (ttm)	548.40M -5.6%
Net Income	10.17M -85.7%
EPS	0.03 -85.9%
Shares Out	356.45M
PE Ratio	161.33
Forward PE	n/a
Dividend	0.03 (0.65%)
Ex-Dividend Date	Jun 20, 2025

Volume	2,428,301
Open	4.630
Previous Close	4.640
Day's Range	4.600 - 4.650
52-Week Range	4.260 - 9.350
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About Ginwa Enterprise (Group)

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1996

Employees 613

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600080

Full Company Profile

Financial Performance

In 2025, Ginwa Enterprise (Group)'s revenue was 544.04 million, a decrease of -7.07% compared to the previous year's 585.46 million. Earnings were 15.58 million, a decrease of -79.12%.

Financial Statements